Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC).

"Funding This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number PB‐PG‐1013‐32064). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. SNV is supported by The Farr Institute @ HeRC. The Farr Institute @ HeRC is supported by a 10‐funder consortium: Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the Medical Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientist Office (Scottish Government Health Directorates), and the Wellcome Trust, (MRC Grant No: MR/K006665/1)."

"The protocol for this systematic review was registered prospectively with the International Prospective Register of Systematic Reviews (PROSPERO CRD42016036540) . We report our review in accordance with PRISMA guidelines . Protocol registration: The systematic review protocol is registered prospectively on PROSPERO (International Prospective Register of Systematic Reviews) (CRD42016036540)."